8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)
Published . Updated .
Key takeaways
- 8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 10 (a notice of a material company event).
- Exposed: DRMA
- Market reaction: DRMA −17.4% after three sessions
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
8-K - Dermata Therapeutics filed an 8-K with the SEC on Nov 10 (a notice of a material company event).
Directly affected
- DRMA Dermata Therapeutics-15.9% 9d
Named in this report.
Indirectly affected
- No related companies are mapped for this report yet.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| DRMA | +16.49% | +6.72% | base | -0.62% | -0.62% | -17.38% | -17.38% |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Filed: 2026-11-10 AccNo: 0001493152-26-050964 Size: 340 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Dermata Therapeutics (DRMA) has moved since 10 Nov 2026
| Company | When | Move | Status |
|---|---|---|---|
| Dermata Therapeutics (DRMA) | that day | -0.62% | final price |
| Dermata Therapeutics (DRMA) | the next day | -0.62% | final price |
| Dermata Therapeutics (DRMA) | two days later | -17.38% | final price |
| Dermata Therapeutics (DRMA) | three days later | -17.38% | final price |
| Dermata Therapeutics (DRMA) | three days earlier | +6.72% | final price |
| Dermata Therapeutics (DRMA) | five days earlier | +16.49% | final price |
Who is named in “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)”
Companies carried with this story
- DRMA Dermata Therapeutics
In “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer),” Dermata Therapeutics (DRMA) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> DRMA
How “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” reaches Dermata Therapeutics (DRMA)
The 10 Nov 2026 story “8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” names Dermata Therapeutics (DRMA) because of this story.
What ties Dermata Therapeutics (DRMA) to the headline is this: SEC 8-K filing -> direct issuer disclosure -> DRMA
Price levels for Dermata Therapeutics (DRMA)
DRMA traded between 0.71 and 0.91 across 9 sessions. The latest close on file is 0.71.
A simple score for Dermata Therapeutics (DRMA)
14 out of 100
“8-K - Dermata Therapeutics, Inc. (0001853816) (Filer)” scores 14 out of 100. The score uses 1 source, and 1 linked company.